Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Pharmacist Involvement in Rural Hospital’s Medicine Policy Offers Significant Savings
09/15/2021
“The involvement of a clinical pharmacist in the hospital medicines policy in a rural area hospital results with an optimization of investment in medicines and leads to substantial cost savings for the health care system,” researchers...
“The involvement of a clinical pharmacist in the hospital medicines policy in a rural area hospital results with an optimization of investment in medicines and leads to substantial cost savings for the health care system,” researchers...
“The involvement of a clinical...
09/15/2021
Pharmacy Learning Network
News
Student Pharmacists, Med Students Glean Knowledge Through Precision Medicine Teams
09/15/2021
“The teams resolved pharmacogenomics patient cases, medical students wrote prescriptions for altered drug therapy based on the pharmacogenomics profiles of the patients, and pharmacy students assessed and provided feedback to medical students...
“The teams resolved pharmacogenomics patient cases, medical students wrote prescriptions for altered drug therapy based on the pharmacogenomics profiles of the patients, and pharmacy students assessed and provided feedback to medical students...
“The teams resolved...
09/15/2021
Pharmacy Learning Network

Advertisement

News
Pharmacy Students Ready to Address Vaccine Hesitancy
09/15/2021
“Students held beliefs of responsibility for limiting non-vaccination,” researchers wrote, “but felt less confident in addressing concerns regarding specific vaccine components and immune system overload.”
“Students held beliefs of responsibility for limiting non-vaccination,” researchers wrote, “but felt less confident in addressing concerns regarding specific vaccine components and immune system overload.”
“Students held beliefs of...
09/15/2021
Pharmacy Learning Network
News
Blood Thinner Recalled
09/10/2021
A Class II recall has been issued for 500-count bottles of a prescription blood thinner used to prevent heart problems.
A Class II recall has been issued for 500-count bottles of a prescription blood thinner used to prevent heart problems.
A Class II recall has been...
09/10/2021
Pharmacy Learning Network
News
Muscle Relaxant Recall Spans Three Labelers
09/10/2021
The FDA issued a Class II recall of more than 19,000 bottles of a prescription muscle relaxant across three labelers.
The FDA issued a Class II recall of more than 19,000 bottles of a prescription muscle relaxant across three labelers.
The FDA issued a Class II recall...
09/10/2021
Pharmacy Learning Network

Advertisement

News
OTC Pain Reliever Under Recall
09/10/2021
The FDA issued a Class II recall for an over-the-counter pain medication due to deviations from Current Good Manufacturing Practice regulations.
The FDA issued a Class II recall for an over-the-counter pain medication due to deviations from Current Good Manufacturing Practice regulations.
The FDA issued a Class II recall...
09/10/2021
Pharmacy Learning Network
News
Pharmacist Recommendations Reduce Medication-Related Harm
09/07/2021
“Clinic pharmacists in multidisciplinary outpatient clinics are effective at identifying and resolving medication-related problems,” study authors wrote.
“Clinic pharmacists in multidisciplinary outpatient clinics are effective at identifying and resolving medication-related problems,” study authors wrote.
“Clinic pharmacists in...
09/07/2021
Pharmacy Learning Network
News
From Uber Rides to Patient Advocates: What It Takes to Increase ER Addiction Treatment
09/03/2021
Despite widespread consensus on the importance of addiction treatment in the ER, many hospitals fail to screen for substance use, offer medications to treat opioid use disorder, or connect patients to follow-up care.
Despite widespread consensus on the importance of addiction treatment in the ER, many hospitals fail to screen for substance use, offer medications to treat opioid use disorder, or connect patients to follow-up care.
Despite widespread consensus on...
09/03/2021
Pharmacy Learning Network

Advertisement

News
Mislabeling of Drug Autoinjector Prompts Recall
09/03/2021
A labeling error has prompted Eli Lilly & Company to recall a prescription medication used to help control high blood sugar in people with type 2 diabetes.
A labeling error has prompted Eli Lilly & Company to recall a prescription medication used to help control high blood sugar in people with type 2 diabetes.
A labeling error has prompted...
09/03/2021
Pharmacy Learning Network
News
Class I Recall for Contaminated IV Bags
09/03/2021
A Class I recall is active for a prescription treatment indicated for patients with high potassium, irregular heartbeat, or metabolic acidosis.
A Class I recall is active for a prescription treatment indicated for patients with high potassium, irregular heartbeat, or metabolic acidosis.
A Class I recall is active for a...
09/03/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use